The Rise of Hybrid Clinical Trials

whitePaper | January 27, 2023

Big Pharma conducted most of its early-stage clinical studies in the West before incorporating Asian locations in later phase studies. Though the Asian region had limited experience in the beginning, over time, researchers’ and local regional experience.

whitePaper | December 20, 2022

During the COVID-19 pandemic, drug overdose deaths have increased. At the same time, access to and utilization of substance use disorder treatment services have decreased.

whitePaper | August 7, 2023

Improving patient safety and protecting healthcare from cybersecurity threats is our top priority at Health-ISAC. The healthcare sector is essential to a country’s national security infrastructure. Cyber-attacks on healthcare systems can have broader implications for public health and national security.

whitePaper | January 9, 2020

Radiation therapy is one of the most common treatments used to fight cancer in the U.S., with more than half of cancer patients receiving it either alone or in combination with other medical interventions.1 With the traditional approach to radiation therapy, the dose and schedule is tailored to the tumor type, location, and stage of growth, but only infrequently updated in light of changes after treatment starts. Experts in adaptive therapy are looking to deliver a more personalized treatment strategy guided by the individual patient’s needs.

whitePaper | August 23, 2022

As the market enters the post-pandemic era, payers and providers are tasked with providing a customer and employee experience that keeps pace with that offered by a new wave of digital-native challengers.

whitePaper | February 23, 2022

Currently, no federal law protects consumers against “surprise” bills from out-of-network ground ambulance providers. Some state and local governments regulate ground ambulance surprise billing practices.